FDA to Revise 20-Year-Old ICH Reproductive Risks Guideline

International Pharmaceutical Regulatory Monitor
A A
The FDA published an ICH-developed revision to its industry guideline on the detection of reproductive risks in new drugs.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor